近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial HypertensionMohamed, N. A., Ahmetaj-Shala, B., Duluc, L., Mackenzie, L. S., Kirkby, N. S., Reed, D. M., Lickiss, P. D., Davies, R. P., Freeman, G. R., Wojciak-Stothard, B., Chester, A. H., El-Sherbiny, I. M., Mitchell, J. A. & Yacoub, M. H. Apr 2016 In : Journal of cardiovascular translational research. 9, 2, p. 162-164
Evidence that Diclofenac and Celecoxib are thyroid hormone receptor beta antagonistsZloh, M., Perez Diaz, N., Tang, L., Patel, P. & MacKenzie, L. S. 1 Feb 2016 In : Life sciences. 146, p. 66-72
Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and NeuropathiesShamsaldeen, Y., MacKenzie, L., Lione, L. & Benham, C. 2016 In : Current Drug Metabolism. 17, 4, p. 359-367 8 p.
In silico modelling of prostacyclin and other lipid mediators to nuclear receptors reveal novel thyroid hormone beta receptor antagonist properties.Perez Diaz, N., Zloh, M., Patel, P. & MacKenzie, L. S. 11 Dec 2015 In : Prostaglandins and Other Lipid Mediators. 122, p. 18-27
Reply to Letter Regarding Article, "Evidence That Links Loss of Cyclooxygenase-2 With Increased Asymmetric Dimethylarginine: Novel Explanation of Cardiovascular Side Effects Associated With Anti-Inflammatory Drugs"Ahmetaj-Shala, B., Kirkby, N. S., Knowles, R., Al'Yamani, M., Mazi, S., Wang, Z., Tucker, A. T., Mackenzie, L. S., Armstrong, P. C. J., Nüsing, R. M., Tomlinson, J. A. P., Warner, T. D., Leiper, J. & Mitchell, J. A. 27 Oct 2015 In : Circulation. 132, 17, p. e213-4
Identification of novel compounds that inhibit S100P and RAGE binding as a new therapy for Pancreatic CancerMacKenzie, L. Aug 2015 1 p.
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsAhmetaj-Shala, B., Kirkby, N. S., Knowles, R., Al'Yamani, M., Mazi, S., Wang, Z., Tucker, A. T., Mackenzie, L., Armstrong, P. C. J., Nüsing, R. M., Tomlinson, J. A. P., Warner, T. D., Leiper, J. & Mitchell, J. A. 17 Feb 2015 In : Circulation. 131, 7, p. 633-42 10 p.
Linking Induction and Transrepression of PPARβ/δ with Cellular FunctionPerez Diaz, N. & MacKenzie, L. S. 26 Jan 2015 In : Annual Research and Review in Biology. 6, 4, p. 253-263
Role of prostacyclin in pulmonary hypertensionMitchell, J. A., Ahmetaj-Shala, B., Kirkby, N., Wright, W. R., MacKenzie, L. S., Reed, D. & Mohamed, N. 31 Dec 2014 In : Global Cardiology Science and Practice. 2014, 4, 12 p., 53
The PPARβ/δ agonist GW0742 prevents LPS-induced nitrite production in rat parenchyma but not in aorta or pulmonary arteriesPerez Diaz, N., Barakat, J., Perez-Vizcaino, F., Moreno, L. & MacKenzie, L. S. Dec 2014 In : pA2 Online. 12, 3, 215P
Selective inhibition of NADPH Oxidase reverses the over contraction of diabetic rat aortaRehman, A. U., Dugic, E., Benham, C., Lione, L. & MacKenzie, L. S. 2014 In : Redox Biology. 2, p. 61-64
Harnessing the benefits of PPARβ/δ agonistsMacKenzie, L. S. & Lione, L. Dec 2013 In : Life Sciences. 93, 25-26, p. 963-967
Linking Phospholipase C isoforms with differentiation function in human vascular smooth muscle cellsMacKenzie, L. S., Lymn, J. & Hughes, A. D. Dec 2013 In : BBA - Molecular Cell Research . 1833, 12, p. 3006-3012
Aspirin triggered 15-epi-lipoxin A4 predicts cyclo-oxygenase-2 in the lungs of LPS treated mice but not in the circulation: implications for a clinical testKirkby, N., Chan, M. V., Lundberg, M. H., MacKenzie, L., Leadbeater, P. D. M., Milne, G. L., Potter, C. M., Al-Yamani, M., Adeyemi, O., Warner, T. D. & Mitchell, J. A. Oct 2013 In : FASEB Journal. 27, p. 3938-46
NADPH oxidase is the source of ROS in STZ rat aorta: use of the novel highly selective NOX inhibitor VAS2870Dugic, E., Shamsaldeen, Y., Benham, C. D. & MacKenzie, L. Sep 2013 Young Life Scientists Symposium 2013.
LC-MS/MS Confirms That COX-1 Drives Vascular Prostacyclin Whilst Gene Expression Pattern Reveals Non-Vascular Sites of COX-2 ExpressionKirkby, N. S., Zaiss, A. K., Urquhart, P., Jiao, J., Austin, P. J., Al-Yamani, M., Lundberg, M. H., MacKenzie, L., Warner, T. D., Nicolaou, A., Herschman, H. R. & Mitchell, J. A. 9 Jul 2013 In : PLoS ONE. 8, 7, e69524
Nitric oxide-dependent vasodilation is compromised in isolated pulmonary arteries from COX knockout miceWright, W., MacKenzie, L. S., Kirkby, N. S. & Mitchell, J. A. Apr 2013 In : FASEB Journal. 27, 1 p., lb603
Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR) is involved in vascular functionBucci, M., Vellecco, V., Brancaleone, V., Roviezzo, F., Mattace Raso, G., Ianaro, A., Meli, R., Cirino, G., Harrington, L., Lungarella, G. & De Palma, R. 2013 In : British Journal of Pharmacology. 168, 2, p. 411-420 10 p.
Vasodilation induced by PPARβ /δ agonists is greater at higher pressures than lower pressures in rat pulmonary arteriesMacKenzie, L. S., Wright, W. R., Warner, T. D. & Mitchell, J. A. Dec 2012
Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular systemKirkby, N. S., Lundberg, M. H., Harrington, L. S., Leadbeater, P. D. M., Potter, C. M. F., Al-Yamani, M., Adeyemi, O., Mitchell, J. A., Warner, T. D. & Milne, G. L. 23 Oct 2012 In : Proceedings of the National Academy of Sciences of the United States of America. 109, 43, p. 17597-17602 6 p.